BP
ZBIO

Ballentine Partners’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History

Ballentine Partners’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,000
Closed -$104K – 433
2017
Q3 		$104K Buy
+5,000
New +$104K 0.01% 376